Recursion Pharmaceuticals Investor Relations Material
Latest events
Q4 2024
Recursion Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Recursion Pharmaceuticals Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
Operating revenue
Grant revenue
Expenses by
Financials
Recursion Pharmaceuticals, Inc. focuses on the development of therapeutics for the treatment of human disease by decoding biology. Their goal is to utilize automation technologies to industrialize drug discovery and replace ineffective trial-and-error drug screening with a streamlined process for identifying new therapeutics.
Key slides for Recursion Pharmaceuticals Inc
Q2 2024
Recursion Pharmaceuticals Inc
Q2 2024
Recursion Pharmaceuticals Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
RXRX
Country
🇺🇸 United States